- SEK53.81bn
- SEK60.84bn
- SEK34.97bn
JPM cuts Getinge's PT by 11% in tough market
Europe Research Roundup: Adidas AG , Crest Nicholson Holdings , Standard Chartered
Brief: FDA Identified Getinge's Recall Of Vaporizer Sevoflurane Maquet Filling As Class I Recall
Brief: Getinge Granted U.S. FDA 510(K) Clearance For Its Innovative Clinical Decision Support Software Talis +Acg
Brief: Getinge Sees Acute Care Therapies 2024-2028 Net Sales Organic Growth Of 3-5%
Getinge heart device quality issues weigh as co issues new outlook target
Getinge limits sale of heart devices in the US after FDA warning
Brief: Getinge Says Financial Target 2024-2028 Is Adjusted EPS Growth Of Above 12% On Average
Medical gear maker Getinge falls after FDA issues safety warning
Medical gear maker Getinge plummets after FDA issues safety warning
US FDA advises healthcare facilities to switch from Getinge's heart devices (updated)
US FDA recommends healthcare providers switch from Getinge's heart devices
Europe Research Roundup: Adriatic Metals, Diageo, GB Group
Brief: Getinge Sees FY 2024 Quality-Related Costs At About Half Of Costs In 2023
Medical gear maker Getinge's Q1 core profit beats expectations (updated)
Brief: Getinge Keeps 2024 Net Sales Outlook Unchanged
Medical gear maker Getinge's Q1 core profit beats expectations
Brief: Getinge Q1 Adjusted EBITA SEK 842 Million Vs. IBES Estimate SEK 809.5 Million
Earnings Poll: Getinge AB first quarter results due on April 22